1415753-57-9

Basic information

• Product Name: C₃₅H₄₄N₂O₇Si
• Synonyms: C₃₅H₄₄N₂O₇Si
• CAS NO: 1415753-57-9
• Molecular Weight: 632.829
• Mol File: 1415753-57-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₃₅H₄₄N₂O₇Si(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₅H₄₄N₂O₇Si(1415753-57-9)
• EPA Substance Registry System: C₃₅H₄₄N₂O₇Si(1415753-57-9)

Safety Data

• Hazardous Substances Data: 1415753-57-9(Hazardous Substances Data)

Upstream product

• 13154-24-0 triisopropylsilyl chloride 
• 153-98-0 serotonin hydrochloride 
• 745060-05-3 O-TIPS-serotonin 
• 17422-74-1 3-Formylchromone 
• 762-42-5 dimethyl acetylenedicarboxylate 

Downstream Products

• 1415753-58-0 C₃₈H₄₈N₂O₇Si 

Relevant articles and documents

Substituted indolo [2,3-a] quinolizines in the treatment of cancer

The present invention relates to novel substituted indolo [2,3-a] quinolizines of the general formula (I) and stereoisomeric forms thereof and/or pharmaceutically acceptable salts of these compounds as well as pharmaceutical compositions containing at least one of these substituted indolo [2,3-a] quinolizines together with pharmaceutically acceptable carrier, excipient and/or diluents. Said novel substituted indolo [2,3-a] quinolizines have been identified as useful for the prophylaxis and treatment of cancer by the induction of strong mitotic delays, chromosomal misalignments and mitotic tri- and multipolarization leading to cell cycle stop and apoptosis. Furthermore a synthesis for preparation of the substituted indolo [2,3-a] quinolizines is disclosed in the present invention.